1. Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company  Eli Lilly and Company
  2. Eli Lilly shot helped patients lose 29% of body weight  Financial Times
  3. Major Weight Loss and Knee-Pain Relief Seen With New Eli Lilly Drug  The New York Times
  4. Major weight loss, pain relief seen with Eli Lilly’s next-gen drug in late-stage trial  Fox Business
  5. Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial  CNBC